Related Experiment Video
Updated: Dec 16, 2025

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Computationally Designed Cyclic Peptides Derived from an Antibody Loop Increase Breadth of Binding for Influenza
Alexander M Sevy1, Iuliia M Gilchuk2, Benjamin P Brown3
1Chemical & Physical Biology Program, Vanderbilt University, Nashville, TN 37235, USA; Center for Structural Biology, Vanderbilt University, Nashville, TN 37235, USA; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Researchers designed antibody-mimicking peptides to target influenza hemagglutinin (HA). These peptides show broad binding to HA variants, offering a new strategy against rapidly mutating influenza viruses.
Area of Science:
- Immunology
- Virology
- Structural Biology
Background:
- Influenza hemagglutinin (HA) is a key target for broadly neutralizing antibodies.
- Influenza viruses rapidly evolve resistance through mutations in HA's hypervariable regions, which overlap with antibody binding sites.
- Current antibody therapies face challenges due to viral escape mechanisms.
Purpose of the Study:
- To design peptides that mimic antibody loops for enhanced binding breadth to influenza HA variants.
- To investigate if mimicking the heavy-chain complementarity-determining region 3 (CDRH3) of an anti-influenza antibody can overcome viral escape mutations.
- To explore a novel approach for generating antibody-derived peptides against diverse biological targets.
Main Methods:
- Designed cyclic peptides to mimic the CDRH3 loop of the broadly neutralizing anti-influenza antibody C05.
- Assessed the binding affinity and breadth of these peptides against various influenza HA subtypes.
- Analyzed the structural basis for enhanced recognition by reducing clashes with hypervariable HA residues.
Main Results:
- The designed CDRH3 peptides bound to HA with high affinity (<100 nM), comparable to the parental C05 IgG antibody.
- These peptides demonstrated broader recognition of influenza H4 and H7 subtypes compared to traditional antibodies.
- The improved breadth was attributed to the peptides' ability to avoid interactions with escape-mutated HA regions.
Conclusions:
- Antibody-mimicking peptides, specifically CDRH3-based designs, can achieve high-affinity binding to influenza HA.
- This peptide design strategy enhances recognition of diverse HA antigenic variants, potentially overcoming viral escape.
- This approach offers a versatile platform for developing peptide-based therapeutics against various targets beyond influenza.
Related Concept Videos
Leaky Scanning
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

